Skip to main content

Rigel Pharmaceuticals Inc (RIGL)

Sector
Biotechnology
Last price
$42.92
As of

Kresmion compiles this page from RIGL's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

RIGEL PHARMACEUTICALS INC (RIGL): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-05.

As of . Source: SEC EDGAR filings for RIGL. Method and limitations.

COMPANY DOSSIER

See the full RIGL dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for RIGL on one page. Preview it with sample data, then open it live with a free account.

Preview the RIGL dossier

Active events for RIGL

FREE, NO ACCOUNT

Every event on RIGL, as it fires

You are seeing 5 of 11 events recorded on RIGL since 2026-05-26.

The five above landed across 3 days. The other 6 were recorded on 2 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

RIGL positions held by the managers we follow (2026Q3)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
RENAISSANCE TECHNOLOGIES LLC FundCUSIP 766559702 · 2026Q3$3.5M0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, RIGL

More data on RIGL

RIGL against its peers

RIGL's operating margin of 42.6% ranks in the 88th percentile of 11 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.

MetricRIGLPeer medianPercentilen
Revenue FY294M USD107M USD7111
Gross margin93.3%n/an/a2
Operating margin42.6%-43.8%8811
Net margin124.7%-31.2%8811
Return on equity93.8%-38.7%9716
P / E2.2xn/an/a1
1 year4.9%4.1%5016

Peers (18): SNDX, MGTX, IRWD, CRVS, TBPH, GLUE, PHAR, ARDX, ORIC, LXRX, PRME, SLDB, AURA, JANX, SGMT, XOMA.D, IMTX, SVRA. Left out: LTGO (no annual filing), BBTX (no annual filing), IVA (period gap), AKTS (no annual filing), OBX (no annual filing), CTY (no annual filing), ODTX (no annual filing). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (RIGL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in RIGL on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on RIGL in the last 180 days.

Upstream: SEC EDGAR filings for RIGL

Kresmion, "RIGEL PHARMACEUTICALS INC (RIGL) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/RIGL. Upstream data: SEC EDGAR filings for RIGL.

Link to this data (HTML):

<a href="https://kresmion.com/research/RIGL">RIGEL PHARMACEUTICALS INC (RIGL) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow RIGL on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to RIGL for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the RIGL dossier
Share

The RIGL intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.